Northwestern Mutual Wealth Management
TCRR

Northwestern Mutual Wealth Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-200
Closed -$3K – 2679
2019
Q3 		$3K Buy
+200
New +$3.12K ﹤0.01% 2232

Other funds holding TCRR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northwestern Mutual Wealth Management's TCRR Position: Q4 2019 in Review

Northwestern Mutual Wealth Management sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q4 2019, closing a stake of 200 shares — an estimated $3K sold.

Northwestern Mutual Wealth Management first reported a position in TCRR in Q3 2019 and held it in 1 quarter. The position peaked at $3K in Q3 2019. 45 funds tracked by Wall St. Rank hold TCRR as of Q4 2019.

  • Northwestern Mutual Wealth Management reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 200 TCR2 Therapeutics Inc. Common Stock shares in Q4 2019, an estimated $3K.
  • Northwestern Mutual Wealth Management first reported a position in TCR2 Therapeutics Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's TCR2 Therapeutics Inc. Common Stock position peaked at $3K in Q3 2019.
  • 45 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q4 2019.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2019, filed 13 Feb 2020.